nevirapine has been researched along with Syphilis in 5 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Syphilis: A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case in which an HIV-positive man developed general malaise, skin rash and biochemical hepatitis within days of starting a nevirapine-based antiretroviral treatment regimen." | 7.80 | Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both? ( Helbert, MR; Higgins, SP; Komolafe, AJ; Saxon, CJ, 2014) |
| "Syphilis is associated with increased human immunodeficiency virus acquisition and sexual transmission; we examined impact on human immunodeficiency virus mother-to-child transmission among mother-infant pairs enrolled in the India Six-Week Extended-Dose Nevirapine study." | 3.85 | Maternal Syphilis: An Independent Risk Factor for Mother to Infant Human Immunodeficiency Virus Transmission. ( Bharadwaj, R; Bhat, J; Bhosale, R; Bollinger, R; Gupta, A; Gupte, N; Kinikar, A; Kulkarni, V; Mave, V; McIntire, KN; Patil, S; Suryavanshi, N, 2017) |
| "We report a case in which an HIV-positive man developed general malaise, skin rash and biochemical hepatitis within days of starting a nevirapine-based antiretroviral treatment regimen." | 3.80 | Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both? ( Helbert, MR; Higgins, SP; Komolafe, AJ; Saxon, CJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menegotto, M | 1 |
| Magdaleno, AM | 1 |
| da Silva, CLO | 1 |
| Friedrich, L | 1 |
| da Silva, CH | 1 |
| Kinikar, A | 1 |
| Gupte, N | 1 |
| Bhat, J | 1 |
| Bharadwaj, R | 1 |
| Kulkarni, V | 1 |
| Bhosale, R | 1 |
| McIntire, KN | 1 |
| Mave, V | 1 |
| Suryavanshi, N | 1 |
| Patil, S | 1 |
| Bollinger, R | 1 |
| Gupta, A | 1 |
| Saxon, CJ | 1 |
| Helbert, MR | 1 |
| Komolafe, AJ | 1 |
| Higgins, SP | 1 |
| Shilaih, M | 1 |
| Marzel, A | 1 |
| Braun, DL | 1 |
| Scherrer, AU | 1 |
| Kovari, H | 1 |
| Young, J | 1 |
| Calmy, A | 1 |
| Darling, K | 1 |
| Battegay, M | 1 |
| Hoffmann, M | 1 |
| Bernasconi, E | 1 |
| Thurnheer, MC | 1 |
| Günthard, HF | 1 |
| Kouyos, RD | 1 |
| Welty, TK | 1 |
| Bulterys, M | 1 |
| Welty, ER | 1 |
| Tih, PM | 1 |
| Ndikintum, G | 1 |
| Nkuoh, G | 1 |
| Nkfusai, J | 1 |
| Kayita, J | 1 |
| Nkengasong, JN | 1 |
| Wilfert, CM | 1 |
5 other studies available for nevirapine and Syphilis
| Article | Year |
|---|---|
Mother-to-Child HIV Transmission among Pregnant Women in a City with the Highest Rates of HIV in Brazil.
Topics: Brazil; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmiss | 2022 |
Maternal Syphilis: An Independent Risk Factor for Mother to Infant Human Immunodeficiency Virus Transmission.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Cost-Benefit Anal | 2017 |
Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both?
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diagnosis, Differential; Exanthema; Hepatitis; HIV Inf | 2014 |
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Comorbidity; Female; Heterosexuality; | 2017 |
Integrating prevention of mother-to-child HIV transmission into routine antenatal care: the key to program expansion in Cameroon.
Topics: Adolescent; Adult; Age Factors; Anti-HIV Agents; Cameroon; Counseling; Female; HIV Infections; Human | 2005 |